Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio Growth (3y) (2017 - 2024)
Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio Growth (3y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -27.28% |
| Mar 31, 2024 | 73.44% |
| Dec 31, 2023 | -41.13% |
| Mar 31, 2023 | -68.11% |
| Sep 30, 2022 | -70.05% |
| Jun 30, 2022 | -120.84% |
| Mar 31, 2022 | 0.06% |
| Dec 31, 2021 | 32.22% |
| Sep 30, 2021 | -7.01% |
| Jun 30, 2021 | -54.40% |
| Mar 31, 2021 | -31.44% |
| Dec 31, 2020 | 70.06% |
| Mar 31, 2020 | 639.91% |
| Mar 31, 2019 | -19.24% |
| Dec 31, 2018 | -43.02% |
| Sep 30, 2018 | 26.17% |
| Jun 30, 2018 | 166.07% |
| Mar 31, 2018 | -40.86% |
| Dec 31, 2017 | 75.67% |
| Mar 31, 2017 | -90.61% |